Treventis CEO Christopher Barden attended BioPort, Atlantic Canada’s largest health and life sciences event in Halifax, Nova Scotia. BioPort is the region’s annual forum for education, information, and inspiration of the Atlantic Canadian life sciences ecosystem.
At the event, Dr. Barden networked with the local community about Treventis and particularly as regards its Halifax-based butyrylcholinesterase PET/SPECT diagnostics project.